FDA grants MRI conditional label extension for Nalu Medical’s neurostimulation system
The FDA label extension means Nalu’s system is deemed safe to offer patients without compromising future diagnostic imaging ...
BusinessMirror29m
US FDA removes coconut from food allergen list–PCA
The exclusion of coconut as a major food allergen eases trade barriers for coconut-based products in the US market, according to the Philippine Coconut Authority (PCA). This, after the US Food and ...
Five Alcohol-Free Wines To Try Now – That Actually Taste Delicious
More new AF wine brands are hitting the market every day. Following are a few others to consider: Noughty Sparkling ...
Pharmaceutical Technology1h
J&J’s Spravato receives FDA label expansion for depression monotherapy
The FDA’s decision marks J&J's Spravato as the first monotherapy for adults with treatment-resistant depression.
Regtechtimes on MSN2h
Cartels as Terrorists: Trump’s Bold Move and the Mexican Response
In the hours following his inauguration, President Donald Trump made a controversial declaration: he would label Mexican drug ...
How Labeling Cartels ‘Terrorists’ Could Hurt the U.S. Economy
Isolating U.S. companies from cartel activities could be almost impossible given that the criminal groups operate in sectors ...
KFF Health News on MSN3h
Long-Covid Patients Are Frustrated That Federal Research Hasn’t Found New Treatments
The federal government has allocated $1.15 billion to long-covid research without any new treatments yet brought to market.
Analysis-Trump's bid to label Mexican cartels 'foreign terrorists' poses risks to companies, migrants
President Donald Trump called for the State Department to label Mexican cartels as "foreign terrorist organizations," a move ...
Trump's bid to label Mexican cartels 'foreign terrorists' poses risks to companies, migrants
President Donald Trump called for the State Department to label Mexican cartels as "foreign terrorist organizations," a move ...
How Trump’s Plan to Label Some Drug Cartels ‘Terrorists’ Would Work
His administration would have more power to impose economic penalties and travel restrictions, and potentially even take ...
FiercePharma17h
Johnson & Johnson's Spravato gains FDA nod to be used as a monotherapy
Already on its way to becoming a blockbuster drug, Johnson & Johnson’s Spravato has received another potential boost as the ...
medtechdive19h
Boston Scientific study meets goals for PFA in persistent AFib
The results will support the company’s application for expanded labeling of its popular Farapulse pulsed field ablation system in a larger group of patients with atrial fibrillation.